Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Overview on Vagus Nerve Stimulation Market Key Vendors Scope and Highlights 2021

Tuesday, March 21, 2017 3:13
% of readers think this story is Fact. Add your two cents.

(Before It's News)

ReportsnReports.com adds new research report Global Vagus Nerve Stimulation Market 2017-2021. This report covers the present scenario and the growth prospects of the global vagus nerve stimulation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of genomics biomarkers.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Inquire for more information at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=917298

The following companies are the key players in the global vagus nerve stimulation market: LivaNova, Enteromedics, and ElectroCore. Other Prominent Vendors in the market are: Beijing Medical Equipment and BioControl Medica.

Global Vagus Nerve Stimulation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Purchase directly at http://www.reportsnreports.com/purchase.aspx?name=917298

According to the report, one driver in market is favorable reimbursement and insurance approval policies. For any device to penetrate the market and later to sustain, depends on various factors, such as, positive results on using the device, user-friendliness, and cost of the device, low side effects, and favorable reimbursement policies. In case of VNS devices, most of the conditions are fulfilled, though some variations are observed based on the type of device. The market growth is expected to increase mainly due to the favorable reimbursement, leading to an increased application and significant investments in development of new technologies for the treatment of epilepsy, and other cardiac indications. As per the Centers for Medicare & Medicaid Services (CMS) coverage database, spinal cord stimulators are covered under reimbursement when criteria are met.

Further, the report states that one challenge in market is high maintenance and low battery lifetime. Battery enables the VNS system to operate for few years without any need of recharge or replacements. Though there are few factors that can drain the battery’s power. For instance, battery usage, battery chemistry, usage pattern, and self-discharge can drain the battery. VNS devices use battery power to control the motor neuron. To control dystonic symptom, involuntary muscle contraction that can cause slow and repetitive movement, consumes high battery power. These batteries can wear out in 7 to 10 years. Batteries are implanted in implantable VNS device that provides power to neural stimulation and to keep the device working. For VNS system, a neurostimulator is implanted in the chest.

Inquire for discount at http://www.reportsnreports.com/contacts/discount.aspx?name=917298

Commenting on the report, an analyst said: “One trend in market is shift of surgeons focus toward minimally invasive VNS procedures. Few years ago, VNS procedures were not popular or limited to few developed countries having high standards of healthcare infrastructure. But now, global exposure and availability of many innovative techniques for learning have increased the knowledge of surgeons about VNS devices. Increased communication among the medical fraternity across countries through various media like medical conferences and industrial exhibitions have made the surgeons receive updates about VNS devices. In the Americas, countries like the US and Canada have listed surgeries involving VNS devices in revenue generating category. The patients having resistance toward anti-epileptic drugs are being treated with VNS devices. Simultaneously, the focus of surgeons is increasing to minimize the side effects observed while using these devices.”

About Us:  

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.